Surmodics | SRDX - Loan Capital


Surmodics reported $29.67M in Loan Capital for its fiscal quarter ending in June of 2025.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Align Technology USD 0 0 Dec/2024
Arrowhead Research USD 1.23B 687.3M Mar/2026
Artivion USD 215.35M 2.46M Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
EDAP TMS EUR 1.01M 13K Sep/2025
Edwards Lifesciences USD 600M 1.7M Mar/2026
Haemonetics USD 1.22B 299.58M Mar/2026
Heron Therapeutics USD 140.64M 975K Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Merit Medical Systems USD 735.16M 1.12M Mar/2026
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Nektar Therapeutics USD 63.16M 44.35M Dec/2025
Option Care Health USD 1.15B 1.01M Mar/2026
Stryker USD 14.22B 635M Mar/2026
Surmodics USD 29.67M 116K Jun/2025
Trinity Biotech USD 114.86M 4.81M Sep/2025